Login
$DTIL
$7.20 -$0.37 (4.82%) Live

$DTIL SEC Filings

Filed On Filing
12 Nov 2026 Form 4
10 Nov 2026 144
09 Nov 2026 8-K: Other Events

As previously reported, on November 5, 2026, Precision BioSciences, Inc. (the “Company”) entered into an underwriting agreement relating to the issuance and sale by the Company of 10,235,077 shares of its common stock, $0.000005 par valu...

06 Nov 2026 144
06 Nov 2026 8-K: Other Events

Exhibit 1.1 Precision BioSciences, Inc. 10,235,077 Shares of Common Stock, par value $0.000005 per share and Pre-Funded Warrants to Purchase up to 5,893,964 Shares of Common Stock Underwriting Agreement November 5, 2026 TD Securities (US...

06 Nov 2026 424B5
05 Nov 2026 144
05 Nov 2026 FWP
05 Nov 2026 8-K: Regulation FD Disclosure; Other Events

AASLD 2026 Investor Update: Direct cccDNA Elimination Leads to an Era of Potential Chronic Hepatitis B Viral Cure Confidential

03 Nov 2026 SCHEDULE 13G/A
03 Nov 2026 8-K: Results of Operations and Financial Condition

- PBGENE-HBV late-breaking oral presentation for ELIMINATE-B trial at AASLD's The Liver Meeting® 2026 on November 8; data abstract scheduled for release November 5 -

03 Nov 2026 10-Q
27 Oct 2026 SCHEDULE 13G
30 Sep 2026 Form 4: Frankel Stanley, Director

Bought 1,000 shares ($6K)

29 Sep 2026 Form 4: Germano Geno J, Director

Bought 2,609 shares ($16.4K)

29 Sep 2026 Form 4: Brown Melinda, Director

Bought 1,135 shares ($7.12K)

24 Aug 2026 SCHEDULE 13G/A
24 Aug 2026 8-K: Regulation FD Disclosure; Other Events

-First patient dosed with PBGENE-DMD, the first clinical gene-editing program for DMD –

07 Aug 2026 S-8
06 Aug 2026 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support